• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchLexeo Therapeutics
    Picture of Lexeo Therapeutics logo

    LXEO — Lexeo Therapeutics News Story

    $2.800.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $229.86m
    • Enterprise Value
      $18.74m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LXEO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LXEO Dividends
    All News

    NASDAQ RESUMED AT 09:37 AM

    Picture of Lexeo Therapeutics logoLexeo Therapeutics
    12/01/2026 14:37
    NASDAQ RESUMED  LXEO.O  AT 09:37 AM
    

    Recent news on Lexeo Therapeutics

    See all news
    • Brief: Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia

      22/09/2026 12:01
    • Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020

      05/08/2026 13:19
    • U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

      15/06/2026 19:13
    • U.S. STOCKS ON THE MOVE-Datadog, Terawulf

      15/06/2026 16:50
    • Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease

      15/06/2026 15:11

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.